Cyclo Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview

Cyclo Therapeutics

10/05/2024 15:43

* Cyclo Therapeutics Inc  CYTH.OQ   CYTH.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 13
(estimated) for the period ending March 31 2024
    * The Gainesville Florida Florida-based  company is expected
to
report a 147.8% increase in revenue to $376.67 thousand from
$152 thousand a year ago, according to the mean estimate from 3
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Cyclo Therapeutics Inc
is for
a loss of 20 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The average consensus recommendation for
the pharmaceuticals
peer group is also "Buy".​
    * Wall Street's median 12-month price target for Cyclo
Therapeutics Inc is $3.00​, above​ its last closing price
of $1.45. ​​​

This summary was machine generated May 10 at 14:43 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)